FDA Investigator Savannah E Samp

Savannah E Samp has conducted inspections on 61 sites in 1 countries as of 13 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

13 May 2024

Investigator Role:

FDA Investigator

Redica ID:

100004807

Countries of Inspections:

United States of America

FDA Investigators that have inspected at least one site in common with Savannah E Samp:

Adam S Freeman, Aimee K Contreras, Alexandra M Cossi, Alexis R Ajello, Amanda N Schaupp, Andrew Tadros, Angel K Sandhu, Ashley J Allen Gaines, Benjamin P Stewart, Breena L D'ambrogi, Brian R Henderson, Bruce D Broidy, Bryce A Finger, Capri R Woolridge, Chloe Anne Leong, Cindy W Lewis, Cynthia L Ford, Daniel C Geffin, Daniel Velasquez, David A Lum, Davis, Dejon N Harris, Dustin P Tran, Elaine S Chow, Elodie X Tong Lin, Emal Wahab, Erica R Pomeroy, Estefania Fernandez, Frank P Bianco, Gerard Pde Leon, Grace P Santos, Hanna S Louvau, Ingrid A Zambrana, Ismael Garibay, James A Barreto, James C Lee, PharmD, Jamie L Port, Jane G Choi, Janice R Small, Janice Wai, Jazmine M Welcher, Jeanne A Young, Jennifer Crumb, Jennifer S King, Joanne M Fukuda, Jocelyn T Ramos, John A Liu, Jolene S Hedgecock, Joseph M Willems, Judy C Nepsa, Junes A Valdemoro, Kacie M Crowther, Karen D Phung, Karla J Gibler, Katie T Duong, Kawshalya Pathiraja, Kevin Lee, Kevin P Foley, Kimiko G Casuga, Kin T Moy, Kristin M Abaonza, Krystina M Jackson, Lija V Fellows, Lilia K Vazquez, Linda S Shook, Lisa H Nakagawa, Lorenzo F Edwards, Lorna F Jones, Luis A Solorzano, Lydia S Chan, Mabel M Lee, Makia P Dove, Marco A Solorio, Mark I Nakano, Mary C Wall, Mcgrewp, Megan E Kulas, Michael S Call, Michelle L Tripp, Ngoc T Le, Nicolas C Tolosa, III, Nicole Yuen, Nympha V Florendo, Peter E Baker, Phung, Quynh H Strandberg, Randal Anderson, Randall P Zielinski, Randy L Elsberry, Rocio Guzman Velazquez, Roger D Gawne, Ronald P Boyce, Siobhan A Gallagher, Sondra R Davis, Sonia R Peterson, Steven B Chiu, Steven J Branch, Steven M Galvez, Terrence Gee, Thomas N Adjabeng, Thomas W Gordon, Tiffany Chao, Timothy C Grome, Tomanik'e C Banks, Travelle D Mason, Tuan D Tran, Vi T Au, Victoria L Morgan, Wayne L Jefferson, Wenting Lei, William J Weis, William V Millar, Yen Tso Kuo, Young M Yoon

Savannah E Samp's Documents

Publish Date	Document Type	Title
December, 2022	FDA 483	Ajinomoto Windsor - Form 483, 2023-12-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more